Vudalimab
Product Specifications
CAS Number
2329669-72-7
Target
PD-1/PD-L1
Related Pathways
Immunology/Inflammation, Apoptosis, Cell Cycle/Checkpoint
Bioactivity
Vudalimab, a fully humanized bispecific monoclonal antibody, effectively inhibits both PD-1 and CTLA-4 immune checkpoint receptors. This dual action facilitates the selective activation of T-cells targeting tumors.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx703895-01 100 mL
Complete Medium for Chicken Follicle Basement Membrane Cells
Sign In for Pricing
View Details